113 related articles for article (PubMed ID: 9934459)
1. Design and synthesis of new secretory phospholipase A2 inhibitor of a phospholipid analog.
Iwama S; Segawa M; Fujii S; Ikeda K; Katsumura S
Bioorg Med Chem Lett; 1998 Dec; 8(24):3495-8. PubMed ID: 9934459
[TBL] [Abstract][Full Text] [Related]
2. The structure-activity relationships of a series of suicide inhibitors of phospholipase A2.
Yu L; Ternansky RJ; Victoria EJ; Chang J; Coutts SM
Bioorg Med Chem Lett; 1998 Aug; 8(16):2129-32. PubMed ID: 9873499
[TBL] [Abstract][Full Text] [Related]
3. New phospholipase A2 inhibitor: synthesis and inhibition mechanism of oxazolidinone phospholipid analog.
Iwama S; Matsuda T; Katsumura S; Tani T; Fujii S; Ikeda K; Takehara H
Bioorg Med Chem; 1995 Oct; 3(10):1397-403. PubMed ID: 8564407
[TBL] [Abstract][Full Text] [Related]
4. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
[TBL] [Abstract][Full Text] [Related]
5. Regioselective synthesis of 4- and 7-alkoxyindoles from 2,3-dihalophenols: application to the preparation of indole inhibitors of phospholipase A2.
Sanz R; Castroviejo MP; Guilarte V; Pérez A; Fañanás FJ
J Org Chem; 2007 Jul; 72(14):5113-8. PubMed ID: 17559277
[TBL] [Abstract][Full Text] [Related]
6. 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2.
Boyd HF; Flynn ST; Hickey DM; Ife RJ; Jones M; Leach CA; Macphee CH; Milliner KJ; Rawlings DA; Slingsby BP; Smith SA; Stansfield IG; Tew DG; Theobald CJ
Bioorg Med Chem Lett; 2000 Feb; 10(4):395-8. PubMed ID: 10714508
[TBL] [Abstract][Full Text] [Related]
7. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
de Haas GH; Dijkman R; van Oort MG; Verger R
Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
[TBL] [Abstract][Full Text] [Related]
9. Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.
Cordella-Miele E; Miele L; Mukherjee AB
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10290-4. PubMed ID: 7694288
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors.
Magolda RL; Galbraith W
J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of substituted benzoylacrylic acids as potential antagonists of phospholipase A2].
Nuhn P; Herrmann A; Radman M
Pharmazie; 1999 Feb; 54(2):93-8. PubMed ID: 10084154
[TBL] [Abstract][Full Text] [Related]
12. Enantiospecific synthesis of the phospholipase A2 inhibitors (-)-cinatrin C1 and (+)-cinatrin C3.
Cuzzupe AN; Di Florio R; White JM; Rizzacasa MA
Org Biomol Chem; 2003 Oct; 1(20):3572-7. PubMed ID: 14599020
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.
Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F
Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of lipophilic keto acids by acylation of alkylbenzenes as potential inhibitors of phospholipase A2].
Nuhn P; Radman M; Hermann A; Marx K
Pharmazie; 1998 Dec; 53(12):825-9. PubMed ID: 10189306
[No Abstract] [Full Text] [Related]
15. Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex.
Bennion C; Connolly S; Gensmantel NP; Hallam C; Jackson CG; Primrose WU; Roberts GC; Robinson DH; Slaich PK
J Med Chem; 1992 Aug; 35(16):2939-51. PubMed ID: 1501221
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
17. WA8242A1, A2 and B, novel secretary phospholipase A2 inhibitors produced by Streptomyces violaceusniger. III. Structure elucidation and total synthesis of WA8242B.
Yoshimura S; Otsuka T; Takase S; Okamoto M; Okada S; Hemmi K
J Antibiot (Tokyo); 1998 Jul; 51(7):655-64. PubMed ID: 9727392
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M
J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of lipolytic enzymes. IV. Structural details of acylamino phospholipid analogues important for the potent inhibitory effects on pancreatic phospholipase A2.
de Haas GH; Dijkman R; Ransac S; Verger R
Biochim Biophys Acta; 1990 Oct; 1046(3):249-57. PubMed ID: 2171669
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes.
Khanum SA; Murari SK; Vishwanth BS; Shashikanth S
Bioorg Med Chem Lett; 2005 Sep; 15(18):4100-4. PubMed ID: 15993585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
